menu search

NUVA / NuVasive to Participate in Upcoming Investor Conferences

NuVasive to Participate in Upcoming Investor Conferences
SAN DIEGO , Feb. 27, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will participate in upcoming investor conferences and will be joined by Globus Medical management to discuss the two companies' recent merger announcement and other business topics: Citi 2023 Healthcare Services, MedTech, Tools and HCIT Conference, March 2, 2023 in New York City. The fireside chat will begin at 9:30 a.m. Read More
Posted: Feb 27 2023, 16:10
Author Name: PRNewsWire
Views: 1020100

NUVA News  

NuVasive, Inc. (NUVA) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 10, 2023

NuVasive, Inc. (NUVA) Q1 2023 Earnings Call Transcript

NuVasive, Inc. (NASDAQ:NUVA ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Juliet Cunningham - Vice President, Invest more_horizontal

Globus Medical: Still Very Attractive After NuVasive Selloff

By Seeking Alpha
May 4, 2023

Globus Medical: Still Very Attractive After NuVasive Selloff

Globus Medical caught headlines after announcing the NuVasive merger. Investors have wiped out considerable equity post-announcement, but the worst ma more_horizontal

Is NuVasive (NUVA) a Great Value Stock Right Now?

By Zacks Investment Research
May 1, 2023

Is NuVasive (NUVA) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe more_horizontal

NUVA vs. ABT: Which Stock Is the Better Value Option?

By Zacks Investment Research
April 25, 2023

NUVA vs. ABT: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Products sector might want to consider either NuVasive (NUVA) or Abbott (ABT). But which of these two st more_horizontal

Why Is NuVasive (NUVA) Down 15.9% Since Last Earnings Report?

By Zacks Investment Research
March 24, 2023

Why Is NuVasive (NUVA) Down 15.9% Since Last Earnings Report?

NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? more_horizontal

NuVasive's (NUVA) Precice System Cleared for Pediatric Patients

By Zacks Investment Research
March 21, 2023

NuVasive's (NUVA) Precice System Cleared for Pediatric Patients

NuVasive (NUVA) receives FDA 510(k) clearance for using the Precice limb lengthening system for treating pediatric patients. more_horizontal

NuVasive (NUVA), GMED Merger Aids, Macro Woes Mar Growth

By Zacks Investment Research
March 17, 2023

NuVasive (NUVA), GMED Merger Aids, Macro Woes Mar Growth

According to NuVasive (NUVA), the combined company is set to have an advanced commercial scale and portfolio of clinically proven solutions. more_horizontal

Bear of the Day: NuVasive (NUVA)

By Zacks Investment Research
March 2, 2023

Bear of the Day: NuVasive (NUVA)

Softer results for spinal surgery innovator plus questionable merger have dropped estimates and shares more_horizontal


Search within

Pages Search Results: